Biotechnology: Can the transatlantic trade and investment partnership reconcile EU and US differences on GMOs? Online publication date: Mon, 02-Feb-2015
by Claude J. Chereau
International Journal of Trade and Global Markets (IJTGM), Vol. 7, No. 4, 2014
Abstract: The USA and EU have announced negotiations for a free trade agreement (FTA) to be completed by end of 2014. While tariff barriers between the two entities are limited, their trade is encumbered with non-tariff barriers (NTBs), one of them being their diverging approach to genetically modified organisms (GMOs) in the agriculture and food industries. The USA operates from a science-based perspective while the EU relies on the precautionary principle. This paper reviews the developments of GMOs in both the USA and EU and draws on measures outlined in international organisations and recent trade agreements to explore options for the USA and EU to reconcile their different perspectives within the framework of the transatlantic trade and investment partnership (TTIP).
Online publication date: Mon, 02-Feb-2015
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Trade and Global Markets (IJTGM):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email email@example.com